TARGETING THE SHEDDING OF TRANSMEMBRANE PD-L1 TO ENHANCE THERAPEUTIC EFFICACY OF IMMUNE CHECKPOINT INHIBITORS
$169,499FY2021Department of the ArmyDOD
Icahn School Of Medicine At Mount Sinai, New York NY
Icahn School Of Medicine At Mount Sinai, New York NY